CTABF News and Press, Canntab Therapeutics Ltd

Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the " Corporation ") announces that the Ontario Securities Commission (the " OSC ") has rejected the Corporation's application for a management cease trade order (the ...

TORONTO, ON / ACCESSWIRE / November 22, 2022 / Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF)(FRA:TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing an update on several matters impac...

CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabi...

CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO Canada NewsWire TORONTO , Aug. 2, 2022 /CNW/ - Canntab Therapeutics Limited ( CSE: PILL.CN )( OTCQB: CTABF ) ( FRA: TBF1.F ) (the " Company " or " Canntab "), the l...

Canntab Therapeutics ( OTCQB:CTABF ) on Thursday said it would explore several cost-cutting measures including a temporary reduction in its staff for 60 days. Other measures will include reducing marketing expenses and other non-essential expenses "until market conditions and ...

Canntab Corporate Update Canada NewsWire TORONTO , June 30, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard pill form f...

CANNTAB ANNOUNCES CHANGE OF AUDITOR Canada NewsWire TORONTO , May 30, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard p...

Canntab Engages Hamish Sutherland as Strategic Advisor Canada NewsWire TORONTO , April 13, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and ter...

CANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITED Canada NewsWire Signs Affiliate Program with OnPharm-United with over 600 pharmacies in Ontario Receives approval from the Province of Saskatchewan to begin sales TORONTO , March 23, 20...

Canntab Therapeutics (OTCQB:CTABF) signed an agreement with First Nations Growers GP to create an Indigenous Opiate and Illicit Drug Crisis Plan. The plan will make Canntab's full suite of oral tablet products, which include a range of tetrahydrocannabinol  (THC) and cannabidio...